Insights On Manufacturing Logistics
-
A Step-By-Step Guide To Cell Banking
2/8/2024
Cell banking stands at the forefront of medical advancement. This guide delves into the steps involved in protecting these priceless resources, from cell collection and processing to storage and cell expansion.
-
Uninterrupted Supply To Meet Demand
1/23/2024
Explore a solution for biopharmaceutical companies concerned about the risks an increase in campaign volume can pose to their production timeline.
-
Biotech Down Under with BiomeBank's Dr. Sam Costello
12/20/2023
Merry Christmas, Business of Biotechers! On this Christmas Day release, we’re taking a trip to the land down under to visit with Dr. Sam Costello, managing director and co-founder at Adelaide, Australia-based BiomeBank. We covered some ground on this one, most notably the unique path BiomeBank took to chalking up the first donor-derived microbiome therapeutic approval of its kind, anywhere in the world. In a segment of biotech that’s been particularly battered of late, that’s a big, big win.
-
Custom Formulation Solution Including An Animal-Origin Element
12/18/2023
Explore the customized, multi-component solution designed to meet quality and packaging specifications, while including an animal-origin element, as well as a non-compendial component.
-
Vial Breakage During Lyophilization: Root Causes And Mitigation
12/12/2023
Learn how controlling freezing rates, using specialized vials, and employing optimized stoppering techniques can reduce the risk of vial breakage during lyophilization and ensure high product quality.
-
Reducing Risk For The mRNA Manufacturing Surge
12/8/2023
As the pharma industry strives to leverage mRNA to treat diseases on a global scale, drug sponsors must be innovative and forward-thinking in their approaches to development and manufacturing.
-
Advancements In Small Volumes Drug Freezing Techniques
12/5/2023
Explore the benefits of different freezing techniques for small batches and their ability to meet the specific requirements and characteristics of different drug substances.
-
Optimizing mRNA Formulations In A Bottlenecked & Bifurcated Supply Chain
12/5/2023
Combined Therapeutics CSO Thomas Van Cott, Ph.D. and Omega Therapeutics Executive Director, Process Development and Analytical Sciences Jeff Atkinson, Ph.D. address how to overcome the challenge of screening, developing, and optimizing formulations during preclinical development in a fragmented supply chain and outsourced environment.
-
mRNA Therapeutics: To The Liver, And Beyond!
12/5/2023
This segment from the Bioprocess Online Live event, mRNA Update: Beyond Prophylactic Vaccines, introduces guests, Combined Therapeutics CSO Thomas Van Cott, Ph.D. and Omega Therapeutics Executive Director, Process Development and Analytical Sciences Jeff Atkinson, Ph.D., and features Dr. VanCott addressing progress on targets beyond the liver.
-
Start Pharma 4.0: Examples To Advance Ultra-Cold Storage Of Drug Substances
11/15/2023
See how adopting the standardized and fully automated processes of Industry 4.0 can contribute to your cost efficiency, patient safety, and sustainability in pharmaceutical manufacturing.